Wenge Xing

1.4k total citations
55 papers, 619 citations indexed

About

Wenge Xing is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wenge Xing has authored 55 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hepatology, 17 papers in Epidemiology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wenge Xing's work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Hepatitis C virus research (12 papers) and Hepatitis B Virus Studies (10 papers). Wenge Xing is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Hepatitis C virus research (12 papers) and Hepatitis B Virus Studies (10 papers). Wenge Xing collaborates with scholars based in China, United States and Japan. Wenge Xing's co-authors include Haipeng Yu, Changfu Liu, Tongguo Si, Xueling Yang, Weihao Zhang, Zhi Guo, Yan Jiang, Zhixing Guo, Ti Zhang and Junfeng Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Wenge Xing

49 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenge Xing China 14 262 193 154 127 117 55 619
Sairy Hernandez United States 12 379 1.4× 159 0.8× 103 0.7× 317 2.5× 77 0.7× 25 704
Junji Shibata Japan 10 262 1.0× 138 0.7× 63 0.4× 74 0.6× 134 1.1× 22 577
Corinne Desaint France 13 73 0.3× 160 0.8× 71 0.5× 270 2.1× 73 0.6× 21 717
Sun Suk Kim South Korea 8 306 1.2× 230 1.2× 28 0.2× 80 0.6× 46 0.4× 21 510
Jimmy Hwang United States 14 31 0.1× 153 0.8× 76 0.5× 144 1.1× 124 1.1× 26 631
Meenal Sharma India 14 127 0.5× 150 0.8× 106 0.7× 118 0.9× 90 0.8× 33 554
S. Erb Canada 10 64 0.2× 136 0.7× 62 0.4× 44 0.3× 57 0.5× 14 361
Hongfa Zhu United States 14 108 0.4× 119 0.6× 119 0.8× 204 1.6× 35 0.3× 42 692
Mohammed Al-Adhami United States 14 103 0.4× 158 0.8× 129 0.8× 104 0.8× 39 0.3× 51 729
Tomoteru Kamimura Japan 16 431 1.6× 409 2.1× 28 0.2× 88 0.7× 129 1.1× 54 747

Countries citing papers authored by Wenge Xing

Since Specialization
Citations

This map shows the geographic impact of Wenge Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenge Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenge Xing more than expected).

Fields of papers citing papers by Wenge Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenge Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenge Xing. The network helps show where Wenge Xing may publish in the future.

Co-authorship network of co-authors of Wenge Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Wenge Xing. A scholar is included among the top collaborators of Wenge Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenge Xing. Wenge Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Jian, Wenge Xing, Hui Zheng, et al.. (2025). Seroepidemiology of hepatitis C virus infection in people aged 1–69 years in China: a national, cross-sectional study. The Lancet Public Health. 10(12). e1036–e1044.
3.
Zhang, Weihao, Xiaohui Zhao, Wei Gao, et al.. (2025). Conversion study of hepatocellular carcinoma using HAIC combined with lenvatinib and PD-1/L1 immunotherapy under the guidance of BCLC staging. Frontiers in Immunology. 16. 1596864–1596864.
4.
Liu, Dongming, Changfu Liu, Weihao Zhang, et al.. (2024). Sintilimab, bevacizumab biosimilar, and HAIC for unresectable hepatocellular carcinoma conversion therapy: a prospective, single-arm phase II trial. Neoplasma. 70(6). 811–818. 8 indexed citations
5.
6.
Zhang, Weihao, Yongjie Xie, Xin Yu, et al.. (2023). ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancer. Discover Oncology. 14(1). 87–87. 2 indexed citations
7.
Li, Mei, Kai Zhang, Jian He, et al.. (2023). Hepatic arterial infusion chemotherapy in hepatocellular carcinoma: A bibliometric and knowledge-map analysis. Frontiers in Oncology. 12. 1071860–1071860. 4 indexed citations
8.
Pei, Lijian, et al.. (2022). The signal-to-cutoff ratios to predict HCV infection among people who inject drugs. VirusDisease. 33(4). 363–370. 1 indexed citations
9.
Liu, Changfu, et al.. (2021). ABCB1 and ABCG2 restricts the efficacy of gedatolisib (PF-05212384), a PI3K inhibitor in colorectal cancer cells. Cancer Cell International. 21(1). 108–108. 17 indexed citations
10.
Ren, Yanan, et al.. (2020). An efficient method for simultaneously screening for HIV, syphilis, and HCV based on one dried blood spot sample. Antiviral Research. 181. 104775–104775. 13 indexed citations
11.
Liu, Changfu, Fei Cao, Wenge Xing, et al.. (2019). Efficacy of cryoablation combined with sorafenib for the treatment of advanced renal cell carcinoma. International Journal of Hyperthermia. 36(1). 219–227. 12 indexed citations
12.
13.
Yu, Haipeng, et al.. (2018). Multifactorial analysis of biliary infection after percutaneous transhepatic biliary drainage treatment of malignant biliary obstruction. Journal of Cancer Research and Therapeutics. 14(7). 1503–1503. 12 indexed citations
14.
Yan, Hao, X Y Feng, Maofeng Qiu, et al.. (2016). Development of a New Limiting-Antigen Avidity Dot Immuno-Gold Filtration Assay for HIV-1 Incidence. PLoS ONE. 11(8). e0161183–e0161183. 4 indexed citations
15.
Guo, Zhixing, et al.. (2014). The treatment of paravertebral malignant mesenchymal tumor pain with cryoablation. Cryobiology. 69(1). 169–173. 1 indexed citations
16.
Yan, Hao, Haiying Yu, Wenge Xing, et al.. (2014). Development of a Proficiency Testing Program for the HIV-1 BED Incidence Assay in China. Scientific Reports. 4(1). 4512–4512. 8 indexed citations
17.
Su, Yingying, Zhongping Duan, Jessie Norris, et al.. (2013). Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: A multicenter study in Beijing, China. Journal of Medical Virology. 85(3). 425–432. 27 indexed citations
18.
Qian, Han‐Zhu, Xiwen Zheng, Wenge Xing, et al.. (2011). HIV, HCV, and HBV co-infections in a rural area of Shanxi province with a history of commercial blood donation.. PubMed. 24(3). 207–13. 13 indexed citations
19.
Jiang, Yan, Mary Qiu, Guigen Zhang, et al.. (2010). Quality assurance in the HIV/AIDS laboratory network of China. International Journal of Epidemiology. 39(Supplement 2). ii72–ii78. 22 indexed citations
20.
Qiu, Maofeng, Xin Liu, Yan Jiang, et al.. (2009). Current HIV‐2 diagnostic strategy overestimates HIV‐2 prevalence in China. Journal of Medical Virology. 81(5). 790–797. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sairy Hernandez Breakdown of academic impact, for papers by Junji Shibata Breakdown of academic impact, for papers by Corinne Desaint Breakdown of academic impact, for papers by Sun Suk Kim Breakdown of academic impact, for papers by Jimmy Hwang Breakdown of academic impact, for papers by Meenal Sharma Breakdown of academic impact, for papers by S. Erb Breakdown of academic impact, for papers by Hongfa Zhu Breakdown of academic impact, for papers by Mohammed Al-Adhami Breakdown of academic impact, for papers by Tomoteru Kamimura
Rankless by CCL
2026